GRANULES INDIA LIMITED (GRANULES) financials — quarterly results, P&L, cash flow, balance sheet, shareholding

Granules India Ltd and its subsidiaries are primarily involved in the manufacturing and selling of Active Pharma Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages.[1]

GRANULESUpdated 1 Sept 2026, 2:40

Granules India Limited

Market Cap

₹20,530Cr.

Current Price

₹828

High / Low

₹910/504

Stock P/E

51.0

ROE10.5%
ROCE12.8%
Book Value₹178
Face Value₹1.00
Dividend Yield0.21%

About

Granules India Ltd and its subsidiaries are primarily involved in the manufacturing and selling of Active Pharma Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages.[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days5812212715412299118136127159156131
Inventory Days931051329292103112123100111176151
Days Payable95891161058196123126126125167118
Cash Conversion Cycle56139142140133105107133102144166164
Working Capital Days12165505356594948626260
ROCE %22%20%17%13%12%16%26%16%20%17%11%13%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 1 September 2026 at 2:40


Designed & Shipped by Harshit Bansal